Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ORI Capital
Hong Kong/Wanchai, Hong Kong SAR Chinaori-capital.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ORI Capital Limited is an active Hong Kong– and US-based venture capital firm founded in 2015 that invests globally in early-stage life sciences companies developing innovative therapeutics, diagnostics, drug delivery technologies, and life science tools. The fund focuses on high-mortality disease areas such as cancer, cardiovascular disease, neurodegeneration, diabetes/autoimmune disorders. It leverages its proprietary AI-driven “ORIZON” analytics platform to identify promising opportunities across more than thirty thousand healthcare startups worldwide. Notable exits include Kymab ($1.1B acquisition by Sanofi), Semma Therapeutics ($950M acquisition by Vertex), CG Oncology’s $380M IPO on NASDAQ—demonstrating strong returns for investors while supporting impactful patient-focused innovation.
- Therapeutic areas
- OncologyEndocrinologyRare DiseasesCardiovascularNeurology
- Modalities
- Small molecule (including next-generation small molecules and RNA-targeting small molecules)Protein degradation therapy (protein degraders)Cell therapyRNA therapy (programmable nucleic acid therapies)Synthetic biology-based therapiesGene therapy (via portfolio companies)
- Industry
- Investors
02
Partnerships
None disclosed directly—however has invested alongside major VCs/funds such as Novalis LifeSciences.
Beyond the preview
Go deeper on ORI Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ORI Capital.